Abstract
Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Current Respiratory Medicine Reviews
Title: Pneumonia in Lung Transplant Recipients
Volume: 6 Issue: 3
Author(s): Isabel Otero, Maria P. Sanjuan, Maria del M. Fernandez-Marrube and Hector Verea
Affiliation:
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Abstract: Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Export Options
About this article
Cite this article as:
Otero Isabel, P. Sanjuan Maria, del M. Fernandez-Marrube Maria and Verea Hector, Pneumonia in Lung Transplant Recipients, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526166
DOI https://dx.doi.org/10.2174/157339810791526166 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruzi
Current Medicinal Chemistry Applied Proteomics in Companion Animal Medicine
Current Proteomics Current Therapeutic Options for Alzheimers Disease
Current Genomics Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Immunotherapy for Conformational Diseases
Current Pharmaceutical Design Drug Effects on Drug Targets: Inhibition of Enzymes by Neuroleptics, Antimycotics,Antibiotics and Other Drugs on Human Pathogenic Amoebas and their Antiproliferative Effects
Recent Patents on Anti-Infective Drug Discovery <i>Larrea tridentata</i> and its Biological Activities
Current Topics in Medicinal Chemistry Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy
Current Neuropharmacology Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research
Current Medicinal Chemistry Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Alternative Aβ Immunotherapy Approaches for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews Meningitis Due to Cryptococcus neoformans: Treatment with Posaconazole
Current HIV Research Clinical Pharmacology of Novel Anti-Alzheimer Disease Modifying Medications
Current Topics in Medicinal Chemistry Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies
Current Alzheimer Research